Target intelligence / Profile preview

Cytochrome P450 family 2 subfamily C member 59, pseudogene (CYP2C59P)

Target
CYP2C59P
Molecular classification
Other, Pseudogene
01

Overview

**Cytochrome P450 family 2 subfamily C member 59, pseudogene (CYP2C59P)** is a human gene classified as a pseudogene, meaning it is a DNA sequence similar to a functional gene but is non-functional and does not produce a functional protein product[1][3][5][7]. Unlike related cytochrome P450 genes (such as CYP2C9), CYP2C59P has no known enzymatic activity or role in drug metabolism or disease and is not considered a therapeutic target, receptor, enzyme, or clinically relevant biomolecule. It is not listed in gene-disease or drug-interaction databases and has no known biological or pharmacological function in human health or disease. **Key points**: - CYP2C59P is a pseudogene and does not encode an active protein or enzyme[1][3][5]. - It has no role in xenobiotic metabolism, pharmacology, or disease, unlike members such as CYP2C9[2][6][8]. - It is not a therapeutic or diagnostic target, and there are no known drugs, biomarkers, or safety considerations associated with this locus. **Note:** - The presence of "pseudogene" in the name and absence in drug/disease/functional databases indicate that this gene is non-functional—and referencing it as a therapeutic target is incorrect[1][3][5][7]. - Do not confuse CYP2C59P with functional cytochrome P450 family members such as CYP2C9, which is a major drug-metabolizing enzyme.

Other names
CYP2C9-de2c3cCYP2C59Pcytochrome P450 family 2 subfamily C member 59, pseudogenecytochrome P450, family 2, subfamily C, polypeptide 59, pseudogene

Beyond the preview

Go deeper on Cytochrome P450 family 2 subfamily C member 59, pseudogene (CYP2C59P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 family 2 subfamily C member 59, pseudogene (CYP2C59P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call